Student and Exchange Visitor Program
Schedules
TAFS: 070-5378 /X - Student and Exchange Visitor Program
| Previously Approved (Iteration 1) | OMB Action (Iteration 2) | |||||
|---|---|---|---|---|---|---|
| Line # | Split | Description | Amount | Footnotes | Amount | Footnotes |
| 1000 | A | Actual - Unob Bal: Brought forward, Oct 1 | Line added | $119,570,114.00 | ||
| 1000 | E | Estimated - Unob Bal: Brought forward, Oct 1 | $82,826,935.00 | Line removed | ||
| 1021 | Unob Bal: Recov of prior year unpaid obligations | Line added | $165,600.00 | |||
| 1033 | Unob Bal: Recov of prior year paid obligations | Line added | $8,728.00 | |||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $11,000,000.00 | $10,825,672.00 | |||
| 1201 | BA: Mand: Appropriation (special or trust) | Line added | $12,568,049.00 | |||
| 1203 | SEQ | BA: Mand: Appropriation (previously unavailable) | $8,436,000.00 | $9,739,015.00 | ||
| 1232 | SEQ | BA: Mand: New\Unob bal of approps temp reduced | -$8,436,000.00 | See footnotes below | -$9,690,000.00 | |
| Footnotes for line 1232 (SEQ) (Previous): | B1: Amount shown on line 1232 is the required FY 2022 sequester amount in dollars, assuming that the program requires spending authority equal to the amount shown on line 1201. Due to the indefinite nature of the collections deposited in this account, the sequester amount in dollars may not be equal to the sequester amount in dollars reflected in the OMB Report to the Congress on the Joint Sequestration for Fiscal Year 2022. During the remainder of the fiscal year, if the necessary spending authority is different from the amount shown on line 1201, the amount in dollars currently reflected on line 1232 is hereby automatically apportioned as follows: the agency will achieve the reduction by applying a 5.7% reduction to obligations incurred from this account from October 1, 2021 through September 30, 2022. | |||||
| 1250 | BA: Mand: Anticipated appropriation | $148,000,000.00 | $157,431,951.00 | |||
| 1920 | Total budgetary resources avail (disc. and mand.) | $241,826,935.00 | $300,619,129.00 | |||
| 6001 | Category A -- 1st quarter | $24,510,000.00 | $50,543,734.00 | |||
| 6002 | Category A -- 2nd quarter | $33,010,000.00 | $33,010,000.00 | |||
| 6003 | Category A -- 3rd quarter | $56,010,000.00 | $56,010,000.00 | |||
| 6004 | Category A -- 4th quarter | $50,520,000.00 | $24,486,266.00 | |||
| 6170 | Apportioned in FY 2023 | $77,776,935.00 | $136,569,129.00 | |||
| 6190 | Total budgetary resources available | $241,826,935.00 | $300,619,129.00 | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| B1 | Amount shown on line 1232 is the required FY 2022 sequester amount in dollars, assuming that the program requires spending authority equal to the amount shown on line 1201. Due to the indefinite nature of the collections deposited in this account, the sequester amount in dollars may not be equal to the sequester amount in dollars reflected in the OMB Report to the Congress on the Joint Sequestration for Fiscal Year 2022. During the remainder of the fiscal year, if the necessary spending authority is different from the amount shown on line 1201, the amount in dollars currently reflected on line 1232 is hereby automatically apportioned as follows: the agency will achieve the reduction by applying a 5.7% reduction to obligations incurred from this account from October 1, 2021 through September 30, 2022. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.